This study reveals that CSF SHBG, as measured by an automated ECLIA, did not differ across pathological groups, though a trend towards increased levels of CSF SHBG was observed in FTLD-Tau cases compared to FTLD-TDP and controls. The gene discussed is SHBG; the disease is torsades de pointes.